Scott J. Antonia, M.D., Ph.D.
Department Chair, Program Leader, Thoracic Oncology Department Associate Professor Department of Interdisciplinary Oncology and Program Leader of the Immunology Program
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida

Rolf Brekken, Ph.D.
Associate Professor, Hamon Center for Therapeutic Oncology Research
UT Southwestern Medical Center

David Carbone, M.D., Ph.D.
Professor of Medicine, Division of Medical Oncology
Ohio State University’s Ohio State’s Comprehensive Cancer Center at the James Cancer Hospital and Solove Research Institute, Columbus, Ohio

Bruce Chabner, M.D.
Clinical director of Massachusetts General Hospital (MGH) Cancer Center
Chief of Hematology and Oncology at MGH and a Professor of Medicine at Harvard Medical School

Harold F. Dvorak, M.D.
Chief of the Department of Pathology at Beth Israel Deaconess Medical Center
Mallinckrodt Professor of Pathology at Harvard Medical School

Dimitry I. Gabrilovich, M.D., Ph.D.
Christopher M. Davis Professor in Cancer Research, Program Leader, Translational Tumor Immunology
The Wistar Institute, Philadelphia, Pennsylvania

Christopher C. W. Hughes, Ph.D.
Professor, Departments of Molecular Biology and Biochemistry, & Biomedical Engineering
University California Irvine

Håkan Mellstedt, M.D., Ph.D.
Professor of Oncologic Biotherapy, Karolinska Institute and Cancer Centre Karolinska
Karolinska University Hospital, Stockholm, Sweden

Alan J. Schroit, Ph.D.
Professor of Cancer Biology
M.D. Anderson Cancer Center, Houston